An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference52 articles.
1. Hypoxia and metabolic adaptation of cancer cells;Eales;Oncogene,2016
2. Oxygen availability and metabolic adaptations;Nakazawa;Nat Rev Cancer,2016
3. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer;Chouaib;Oncogene,2016
4. Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs;Phillips;Cancer Chemother Pharmacol,2016
5. Hypoxia – a key regulatory factor in tumour growth;Harris;Nat Rev Cancer,2002
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration;JCI Insight;2024-01-09
2. Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability;Radiotherapy and Oncology;2023-09
3. Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based Modelling;Frontiers in Pharmacology;2022-02-08
4. Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy;Pharmaceuticals;2022-02-02
5. Mitochondria-targeting multifunctional nanoplatform for cascade phototherapy and hypoxia-activated chemotherapy;Journal of Nanobiotechnology;2022-01-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3